Navigation Links
Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement
Date:11/4/2009

t between AtriCure and the DOJ is subject to the completion and approval of a written settlement agreement.

Sanford Wittels & Heisler is a renowned class action and qui tam law firm with offices in Washington, D.C., New York, and San Francisco that specializes in qui tam, employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. Individuals with these claims are encouraged to contact Sanford Wittels & Heisler at (202) 742-7777.

SOURCE Sanford Wittels & Heisler, LLP


'/>"/>
SOURCE Sanford Wittels & Heisler, LLP
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
3. ACRO Comments on NEJM Article on Globalization of Clinical Research
4. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
5. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
6. Arpida Provides Further Comments on the Pivotal Phase III Trials
7. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
10. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
11. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3EPIX Pharmaceuticals Inc Announces August 25 2009 for the Auction Sale of Equipment and September 30 2009 for the Auction Sale of the Intellectual 53631 1EPIX Pharmaceuticals Inc Announces August 25 2009 for the Auction Sale of Equipment and September 30 2009 for the Auction Sale of the Intellectual 53631 2Are kids today truly more autonomous 3F 53627 1Are kids today truly more autonomous 3F 53627 2Brain difference in psychopaths identified 9468 1Brain difference in psychopaths identified 9468 2